Mehjabeen Rahman, J.D.

Mehjabeen Rahman, J.D., is a versatile legal professional, currently a Law Graduate at Gutman, Mintz, Baker & Sonnenfeldt. She has been serving as a Staff Writer and Legal Blog Author for the Expert Institute since September 2015, where she conducts expert interviews and writes advisory articles for the legal community.

Her hands-on legal experience includes internships at the Kings County District Attorney's Office in the Special Victims Bureau and the Community Legal Assistance- Law Reform Advocacy Clinic. At the DA's office, Mehjabeen assisted in case preparation and trial observation, and at the Advocacy Clinic, she managed litigation for a Civil Action case and argued pretrial motions. Additionally, she gained experience in criminal defense and motion drafting during her internship at Renfro, Driscoll & Foster, LLP.

Mehjabeen earned her Juris Doctor from Maurice A. Deane School of Law at Hofstra University, where she was a Mock Trial Team member, Clinic Student, and Associate Editor for the Hofstra Labor and Employment Law Journal. Her legal education and practical experiences underscore her expertise in legal research, writing, and trial preparation.

Mehjabeen Rahman, J.D.

Mastering Expert Witness Discovery: The Ultimate Guide to Rule 26

As any litigator is well aware, Rule 26 of the Federal Rules of Civil Procedure (FRCP) governs the disclosure of expert witness testimony during the discovery stage of litigation. But in 2010, significant amendments were made to the rule. These new changes were designed to address some practical problems from a 1993 amendment that had

Posted on April 26, 2016 in Working with Experts

5 Potential MDLs To Watch This September

This year, several companies that provide widely familiar goods and services including Uber, Chrysler, Roundup, Johnson & Johnson and the makers of psychiatric drug Abilify are facing quickly growing lawsuits across the country. The lawsuits include claims involving everything from rogue Jeeps to talcum powder, lawn weed-killer and anti-psychotic drugs. Motions to consolidate and transfer

Posted on September 20, 2016 in News